CAS 2378617-96-8

HWL-088

CAS : 2378617-96-8

HWL-088 is an analog of a Chinese medicinal compound that has shown potent anticancer activity. It works by inhibiting kinases, which are enzymes involved in cell signaling and regulation. HWL-088 has been shown to induce apoptosis, or programmed cell death, in cancer cells. This compound is a potent inhibitor of protein kinases, which play a crucial role in the growth and proliferation of cancer cells. HWL-088 has also demonstrated efficacy against various human tumor cell lines. Additionally, this compound can be detected in urine after administration, making it a promising candidate for clinical use as an anticancer agent.

Formule : C₂₂H₁₉FO₄

Degré de pureté : Min. 95%

Masse moléculaire : 366.4 g/mol

Ref: 3D-DVD61796

HWL-088

CAS : 2378617-96-8

HWL-088 is a potent free fatty acid receptor 1 (FFA1/GPR40) agonist. HWL-088 significantly improves glucose tolerance in normal and diabetic models.

Formule : C₂₂H₁₉FO₄

Couleur et forme : Solid

Masse moléculaire : 366.38

Ref: TM-T11583